Fusion Pharmaceuticals
enhanced efficacy in a mouse tumor model | Fusion Pharmaceuticals
Company
Deck Type
IPO
Sector
Industry
Deck date
June 2020
Slide
31 of 49
Related slides by other companies
OKYO Pharma
Results
June 2023
validation efficacy in dry eye mouse model | OKYO Pharma
Recursion Pharmaceuticals
Investor Day
January 2023
clinical efficacy found in in mice models led to significant progression free survival further confidence preclinical studies confirming insight | Recursion Pharmaceuticals
MAIA Biotechnology
Investor Presentation
November 2023
excellent efficacy in models | MAIA Biotechnology
MAIA Biotechnology
Investor Presentation
January 2024
excellent efficacy in models liver cancer | MAIA Biotechnology
Other recent decks by Fusion Pharmaceuticals
See all presentations (4 decks)
Investor Presentation
January 2024
Investor Presentation
November 2023
Investor Presentation
August 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io